Overview
FMS market data
Price History
FMS price chart
Valuation & Profitability
- P/E (TTM)
- 11.83 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.36 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.24 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 3.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 4.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $34.57 – $47.86 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.2B · P/B 0.89 · P/S 0.58.
Company News
Bernstein Maintains Market Perform on Fresenius Medical Care, Raises Price Target to $25.8Benzinga · Aug 6, 2026, 4:39 PM
Fresenius Medical Care Q2 2026 Earnings Call TranscriptBenzinga · Aug 4, 2026, 12:12 PM
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Aug 4, 2026, 12:04 PM
Fresenius Medical Care shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 4, 2026, 11:32 AM
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B EstBenzinga · Aug 4, 2026, 8:20 AM
Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B EstimateBenzinga · Aug 3, 2026, 8:46 PM
New Cross-Study Analysis from Spherix Global Insights Combines Physician, Dietitian and Patient Chart Data to Show Access Barriers Still Curbing Xphozah Uptake Ahead of the TDAPA CliffGlobenewswire Inc · Jul 29, 2026, 3:15 PM
Fresenius Medical Care Announces BEACON-US Initiative Expanding US High-Volume Hemodiafiltration Access; Says Over 70% Of Treatments Reach 23-Liter Convective Volume TargetBenzinga · Jul 29, 2026, 1:04 PM
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS InsiderGlobenewswire Inc · Jul 20, 2026, 1:00 PM
Fresenius Medical Care Announces ~€1B Stock BuybackBenzinga · May 26, 2026, 11:10 AM